Precision medicine and drug development in Alzheimer’s disease: the importance of sexual dimorphism and patient stratification
Year: 2018
Type: review
Source: Frontiers in Neuroendocrinology
Institutions: Centre National de la Recherche Scientifique, Inserm, Sorbonne Université, Assistance Publique – Hôpitaux de Paris, Pitié-Salpêtrière Hospital, AXA Research Fund, Institut du Cerveau, Alzheimer Precision Medicine, University of Pisa, Hanyang University Seoul Hospital, Hanyang University, Ghent University Hospital, Sapienza University of Rome, European Brain Research Institute, University of Rome Tor Vergata
Language: English
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Open Access status: green
Funder: Agence Nationale de la Recherche
OpenAlex ID: W2808696240
